JPS58144375A - 新規な１，３−二置換イミダゾ−ル誘導体およびその製造方法 - Google Patents
新規な１，３−二置換イミダゾ−ル誘導体およびその製造方法Info
- Publication number
- JPS58144375A JPS58144375A JP57027042A JP2704282A JPS58144375A JP S58144375 A JPS58144375 A JP S58144375A JP 57027042 A JP57027042 A JP 57027042A JP 2704282 A JP2704282 A JP 2704282A JP S58144375 A JPS58144375 A JP S58144375A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- imidazole derivative
- general formula
- represented
- derivative according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 1,3-disubstituted imidazole Chemical class 0.000 title claims abstract description 9
- 239000002253 acid Substances 0.000 claims abstract description 17
- 150000002460 imidazoles Chemical class 0.000 claims abstract description 16
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 4
- 125000002252 acyl group Chemical group 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 239000004215 Carbon black (E152) Substances 0.000 claims description 3
- 229930195733 hydrocarbon Natural products 0.000 claims description 3
- 150000002430 hydrocarbons Chemical class 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 37
- 238000000034 method Methods 0.000 abstract description 16
- JBOIAZWJIACNJF-UHFFFAOYSA-N 1h-imidazole;hydroiodide Chemical compound [I-].[NH2+]1C=CN=C1 JBOIAZWJIACNJF-UHFFFAOYSA-N 0.000 abstract description 3
- 108010069102 Thromboxane-A synthase Proteins 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 21
- 238000004519 manufacturing process Methods 0.000 description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000002994 raw material Substances 0.000 description 7
- 239000000543 intermediate Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 238000001914 filtration Methods 0.000 description 5
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- VWUCIBOKNZGWLX-UHFFFAOYSA-N 1h-imidazol-1-ium;bromide Chemical compound [Br-].C1=C[NH+]=CN1 VWUCIBOKNZGWLX-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- VIHYIVKEECZGOU-UHFFFAOYSA-N N-acetylimidazole Chemical compound CC(=O)N1C=CN=C1 VIHYIVKEECZGOU-UHFFFAOYSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- AILBUXWGBTVZKT-UHFFFAOYSA-N 1-bromo-7-methyloctane Chemical compound CC(C)CCCCCCBr AILBUXWGBTVZKT-UHFFFAOYSA-N 0.000 description 1
- NZCHZMUCBWNHJZ-UHFFFAOYSA-N 1-chloro-7-methyloctane Chemical compound CC(C)CCCCCCCl NZCHZMUCBWNHJZ-UHFFFAOYSA-N 0.000 description 1
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 1
- BKJFDZSBZWHRNH-UHFFFAOYSA-N 8-bromooctanoic acid Chemical compound OC(=O)CCCCCCCBr BKJFDZSBZWHRNH-UHFFFAOYSA-N 0.000 description 1
- SJHCDMKHMIJAIW-UHFFFAOYSA-N 8-chloro-2,2-dimethyloctanoic acid Chemical compound OC(=O)C(C)(C)CCCCCCCl SJHCDMKHMIJAIW-UHFFFAOYSA-N 0.000 description 1
- KDOIUCVMDLDXOP-UHFFFAOYSA-N 8-imidazol-1-yloctanoic acid;hydrochloride Chemical group Cl.OC(=O)CCCCCCCN1C=CN=C1 KDOIUCVMDLDXOP-UHFFFAOYSA-N 0.000 description 1
- ATZMBJOEEVXQPA-UHFFFAOYSA-N 8-iodooctanoic acid Chemical compound OC(=O)CCCCCCCI ATZMBJOEEVXQPA-UHFFFAOYSA-N 0.000 description 1
- XEGRKZRPTBNSMN-UHFFFAOYSA-N 9-bromononanoic acid Chemical compound OC(=O)CCCCCCCCBr XEGRKZRPTBNSMN-UHFFFAOYSA-N 0.000 description 1
- DFJLDESPZKERQH-UHFFFAOYSA-N 9-chlorononanoic acid Chemical compound OC(=O)CCCCCCCCCl DFJLDESPZKERQH-UHFFFAOYSA-N 0.000 description 1
- KNTGUFLHSQVAHE-UHFFFAOYSA-N 9-iodononanoic acid Chemical compound OC(=O)CCCCCCCCI KNTGUFLHSQVAHE-UHFFFAOYSA-N 0.000 description 1
- 101100087531 Caenorhabditis elegans rom-2 gene Proteins 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- GDBUORNHWAZSNU-UHFFFAOYSA-N N-propanoylimidazole Chemical compound CCC(=O)N1C=CN=C1 GDBUORNHWAZSNU-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- SHOBMTILPVNCAD-UHFFFAOYSA-N ethyl 8-bromo-2-methyloctanoate Chemical compound CCOC(=O)C(C)CCCCCCBr SHOBMTILPVNCAD-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 101150111011 ficd gene Proteins 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57027042A JPS58144375A (ja) | 1982-02-22 | 1982-02-22 | 新規な１，３−二置換イミダゾ−ル誘導体およびその製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57027042A JPS58144375A (ja) | 1982-02-22 | 1982-02-22 | 新規な１，３−二置換イミダゾ−ル誘導体およびその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58144375A true JPS58144375A (ja) | 1983-08-27 |
| JPH0314027B2 JPH0314027B2 (enrdf_load_stackoverflow) | 1991-02-25 |
Family
ID=12210005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57027042A Granted JPS58144375A (ja) | 1982-02-22 | 1982-02-22 | 新規な１，３−二置換イミダゾ−ル誘導体およびその製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58144375A (enrdf_load_stackoverflow) |
-
1982
- 1982-02-22 JP JP57027042A patent/JPS58144375A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0314027B2 (enrdf_load_stackoverflow) | 1991-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69531203T2 (de) | Cephalosporinsynthese | |
| US4001223A (en) | Adamantane-piperazine derivatives | |
| US6197998B1 (en) | Process for producing N-glycyltyrosine and its crystal structure | |
| DE69714358T2 (de) | 9,10-disubstituierte campothecinderivate mit antitumoraktivität | |
| JPS58144375A (ja) | 新規な１，３−二置換イミダゾ−ル誘導体およびその製造方法 | |
| JP3125101B2 (ja) | 光学異性ヒダントインの分割方法 | |
| US3859277A (en) | D-1-1-(' -chloroethyl)-3-(2-oxo-3-hexahydroazepinyl)-1-nitrosourea | |
| KR101557702B1 (ko) | 미티글리니드 칼슘 이수화물의 제조방법 | |
| DE3002553A1 (de) | Verfahren zur herstellung von 6,7- dimethoxy-4-amino-2-eckige klammer auf 4-(2-furoyl)-1-piperazinyl eckige klammer zu chinazolinhydrochlorid | |
| JPS5838261A (ja) | 新規な１，３−二置換イミダゾ−ル誘導体及びその製造方法 | |
| KR102704255B1 (ko) | 독시플루리딘의 제조 방법 | |
| Shiraiwa et al. | Optical resolution by preferential crystallization of (2RS, 3SR)‐2‐amino‐3‐chlorobutanoic acid hydrochloride | |
| Shiraiwa et al. | Optical resolution by preferential crystallization of (RS)‐2‐amino‐3‐chloropropanoic acid hydrochloride | |
| DE2225762C3 (de) | Substituierte Fusarsäuren und Derivate derselben sowie Verfahren zur Herstellung derselben und Arzneimittel mit einem Gehalt derselben | |
| CH616424A5 (enrdf_load_stackoverflow) | ||
| KR910009236B1 (ko) | N-2'-카르복실페닐-4-클로로안트라닐산의 신규 제조방법 | |
| DE2302669A1 (de) | 5-cinnamoylpyrrol-2-essigsaeuren und ihre ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln | |
| JP2688226B2 (ja) | １，３−ジチアン誘導体の製造法 | |
| JPH03251558A (ja) | Ｎ―（３’，４’―ジメトキシシンナモイル）アントラニル酸の製造方法 | |
| JPS59216882A (ja) | ２，４−オキサゾリジンジオン誘導体の製造方法 | |
| DE3016960A1 (de) | Oxoaminosaeurederivate und ihre ungiftigen salze, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| JPH04244088A (ja) | セファロスポリン誘導体 | |
| CH637967A5 (fr) | Produit d'addition du n,n-dimethylacetamide et d'un derive d'un acide cephem-4-carboxylique et procede de sa preparation. | |
| JPH0368571A (ja) | Ｎ―置換２、４、６―トリイミノトリアジン誘導体の製造方法 | |
| ITMI952151A1 (it) | Processo per la preparazione di formilguanina |